MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
62.00
-1.57 (-2.47%)
Jul 24, 2026, 4:00 PM EDT - Market closed
MBX Biosciences Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, MBX Biosciences stock has a consensus rating of "Buy" and an average price target of $69. The average 1-year stock price forecast is 11.29% higher than the current stock price, while the lowest is $19 (-69.35%) and the highest is $91 (+46.77%).
Price Target: $69 (+11.29%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for MBX Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 9 | 9 | 9 | 9 | 9 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 11 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Reiterates $60 → $90 | Buy | Reiterates | $60 → $90 | +45.16% | Jul 23, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jul 15, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $88 | Buy | Reiterates | $88 | +41.94% | Jul 14, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $91 | Buy | Maintains | $91 | +46.77% | Jul 14, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Reiterates $80 | Buy | Reiterates | $80 | +29.03% | Jun 15, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.71
from -2.38
EPS Next Year
-3.60
from -2.71
EPS and Forward PE are based on non-GAAP adjusted numbers.